Banyan Hill is touting Oxford Club’s Alexander Green’s story about how small caps and microcaps will outdistance outperform other stocks. The one he is pushing is a microcap selling at about $3 that uses AI to design new drugs and medicines, earning money on royalties due the company. Claims that Nvidia and Merck are partners. […]
Motley Fool has begun to aggressively tease the technology behind Apple’s “T288” project. Sounds like it may relate to a VR or AR project. Any thoughts?
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
Please note that this is your publicly visible biography - we recommend not including any personal information (phone, email, address, etc.) and ONLY linking to any other pages or profiles you're comfortable sharing with everyone.
